Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 15/20 | 0.59 |
| ▸ | CXCR1 | P25024 | 14/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5656795 | 0.87 | CXCR2 (0.76) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5661096 | 0.86 | CXCR2 (0.67) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5658349 | 0.83 | CXCR2 (0.73) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5659069 | 0.82 | CXCR2 (0.59) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5660773 | 0.82 | CXCR2 (0.52) | CXCR2CXCR1P4HTMKMT2A | |
| SCHEMBL5658828 | 0.82 | CXCR1 (0.51) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5658556 | 0.82 | NPC1 (0.52) | CXCR2CXCR1NPC1RAB9AP4HTM | |
| SCHEMBL5657684 | 0.81 | CXCR1 (0.61) | CXCR2CXCR1NPC1RAB9ALMNA | |
| SCHEMBL5660485 | 0.81 | CXCR2 (0.77) | CXCR2CXCR1NPC1RAB9ALMNA | |
| SCHEMBL5656328 | 0.80 | P4HTM (0.57) | CXCR2CXCR1NPC1RAB9AP4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7176310-B1 | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents | UCB SA (GB) | 2007-02-13 | — | — | US | disclosed |